2021 Sexual Dimorphism in Cancer meeting program

Monday March 22 

16.00-19.30 Swiss Time (11 am -2 pm East Coast US; 8-11 am West Coast US) 

16:00-16:10                        Introductory remarks and overview

                                   Gian Paolo Dotto 

SESSION 1 – Gender medicine, sex determination and cancer susceptibility

16:10-16:35.          Ongoing efforts in gender medicine

                                   Sabine Oertelt-Prigione

Professor of Gender in Primary and Transmural Care, Radboud University , Nijmegen, The Netherlands Sabine.Oertelt-Prigione@radboudumc.nl

16:35-17:00            Sex differences in epidemiology of non-sex related cancers

                                   Melinda Schuurman & Jaike Praagman

Netherlands Cancer Registry, M.Schuurman@iknl.nland j.praagman@IKNL.NL

17:00-17:25             Sex differences in response to anticancer drugs and immune therapy 

                                    Anna Dorothea Wagner and Berna Özdemir

Consultant Department of Oncology Lausanne University Hospital CHUV/ Bern University Hospital (Inselspital)dorothea.wagner@chuv.chBerna.oezdemir@insel.ch

17:25-17:40             Break

17:40-18:00             Beyond dimorphism – Disentangling the science in cancer care for transgender and non-binary people

                                   Dr Alison May Berner

Speciality Trainee and Clinical Research Fellow in Medical Oncology

Barts Cancer Institute&Specialist Registrar in Gender Identity
Gender Identity Clinic, Tavistock and Portman NHS Foundation Trust


18:00-18:25            Genetic basis of sex determination

Head of the Laboratory of Stem Cell Biology and Developmental Genetics at the Francis Crick Institute Robin.Lovell-Badge@crick.ac.uk

18.25 -18:50                       The sex of the intestine and why it matters

                                   Irene Miguel-Aliaga

Genes and Metabolism Section Chair, MRC London Institute of Medical Sciences, and Professor of Genetics and Physiology, Imperial College i.miguel-aliaga@lms.mrc.ac.uk

19:00-20:00            Meet the speakers roundtable.

Tuesday March 23

16:00-19:00 pm Swiss Time (11 am -1:30 pm East Coast US; 8-10:30 am West Coast US)

SESSION 2 – Genetic predisposition and cancer cells genetics

16:00-16:25            Twins, hormones and cancer risk factors

                                   Jaakko Kaprio

Professor of Genetic Epidemiology, Department of Public Health, Faculty of Medicine & Institute for Molecular Medicine FIMM, HiLIFE University of Helsinki jaakko.kaprio@helsinki.fi

16:25-16:50            Genetic determinants of cancer susceptibility : a look to the future

                                   Allan Balmain

Professor of Cancer Genetics, UCSF allan.Balmain@ucsf.edu

16:50-17:15            X chromosome silencing and biological impact

                                   Jeannie Lee

Professor of Genetics (Pathology), Harvard Medical School, Molecular Biologist, Massachusetts General Hospital lee@molbio.mgh.harvard.edu

17:15-17:30            Break

17:30-17:55            “Gender specificity in DNA damage response pathways”

Laura Zannini

Group leader, Institute of Molecular Genetics, National Research Council (IGM-CNR), Pavia, IT laura.zannini@igm.cnr.it

17:55–18:20            “The molecular epidemiology of somatic mutations: how does patient sex influence cancer evolution?”

                                    Paul C. Boutros

Group leader, UCLA PBoutros@mednet.ucla.edu

19:00-20:00                        Meet the speakers roundtable

Wednesday March 24

16:00-19:00 pm Swiss Time (11 am -2 pm East Coast US; 8-11 am West Coast US )

SESSION 3 – gene mutations and cancer

16:00-16:25            Tumor-suppressor genes that escape from X-inactivation

                                   Andrew Lane 

Broad Institute of Harvard and MIT, and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Cambridge, Massachusetts, USA, andrew_lane@dfci.harvard.edu 

16:25-16:50            Sex disparity and the p53 signaling network

Sue Haupt and Yigal Haupt

Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria 3000, Australiasue.haupt@petermac.org

16:50-17:15                        Sex differences in glioblastoma

                                   Joshua B. Rubin

Professor of Pediatrics, Hematology and Oncology, Washington University School of Medicine in St. Louis, rubin_j@wustl.edu

17:15-17:30                        Break

17:30-17:55            Pancreatic Cancer

                                   Alexandros Tzatsos

Group leader, School of Medicine and Health Science, George Washington University, atzatsos@email.gwu.edu

17:55-18:20            Novel Mechanisms of Cancer Emerge When Accounting

                                   for Sex as a Biological Variable

                                   Kenneth Buetow

                                   Professor and CEM Center Director, Arizona State University


18:30-19:30            Meet the speakers roundtable

Thursday March 25

16:00-19:00 pm Swiss Time (11 am -2 pm East Coast US; 8-11 am West Coast US)

SESSION 4 – Hormones and cancer

16:00- 16:25                       Structure/function

                                   Eva Estébanez-Perpina

AR Group leader Institute of Biomedicine of the University of Barcelona (IBUB), evaestebanez@ub.edu

16:25-16:50             Role of local sex steroid synthesis and metabolism in hormonal carcinogenesis

                                    Matti Poutanen

Professor of Physiology, Institute of Biomedicine, University of Turku, Finland matpou@utu.fi

16:50-17:15             Finding Dory: hormone exposure, mutational signatures and estrogen receptor defines the early oncogenesis processes at play in the cell of origin of breast cancer

                                    Luca Magnani

Group leader, Imperial College London,. l.magnani@imperial.ac.uk

17:15-17:30                        Break

17:30-17:55            Sex hormones signaling in male breast cancer

                                   Wilbert Zwart

Group leader, Netherlands Cancer Institute (NKI),w.zwart@nki.nl

17:55-18:20            ER signaling and Melanoma

                                   Todd Ridky

Group leader Department of Dermatology, U. Penn, ridky@pennmedicine.upenn.edu

18:20-18:45            AR signaling in skin cancer

                                   Soumitra Ghosh / Min Ma

UNIL, Department of Biochemistry, soumitra.ghosh@unil.chmin.ma@unil.ch

18:45-19:00            Break

19:00-20:00            Meet the speakers roundtable

Friday March 26

16:00-17:00 pm Swiss Time (11 am -12 pm East Coast US; 8-9 am West Coast US)


16:00-16:25            Gender differences in metabolism

                                   Adriana Maggi

Professor of Pharmacological Biotechnologies, University of Milan,  adriana.maggi@unimi.it

16:25-16:50             “Gene-by-sex interactions regulating mitochondrial functions and cardio-metabolic traits”

                                    Aldons Jake Lusis


16:50-17:15             “Sex differences in brain development and function: Implications for comorbidity of psychiatric and cardiovascular outcomes”

                                    Jill Goldstein

Professor of Psychiatry and Medicine, Harvard Medical School; Executive Director, Innovation Center on Sex Differences in Medicine, Massachusetts General Hospitaljill_goldstein@hms.harvard.edu

17:15-17:30            Break

17:30-18:00            ICPI life time achievement cancer prevention award

Tony Howell



18:00-18:50            Poster awards (with awardees’ speed talks) 

18:50-19:15            Sexual dimorphism in cancer : meeting overview

                                   Sarah Seton.Rogers

                                   Chief Editor, Nature Reviews Cancer


19:15 – 19:30          Concluding remarks                                   G. Paolo Dotto